Berberine is a natural plant alkaloid that has been utilized for centuries in traditional Chinese and Ayurvedic medicine. It is derived from several plants, including Berberis, Coptis chinensis (also known as Chinese Goldthread), and Hydrastis canadensis (commonly known as Goldenseal). Berberine has garnered significant interest in modern scientific research due to its diverse range of potential health benefits.

Berberine is recognized for its bright yellow color and has historically been used as a dye, an antimicrobial agent, and for its medicinal properties. It is primarily found in the roots, rhizomes, and stems of the plants from which it is extracted. The compound has a bitter taste and is often used in powdered form or as part of various herbal formulations.

The primary reason berberine has gained attention in contemporary health discussions is due to its potential effects on metabolic health. Studies have shown that berberine may help regulate blood glucose levels, improve lipid profiles, and support weight management. These properties make it a supplement of interest for individuals dealing with metabolic disorders such as type 2 diabetes and hyperlipidemia. Research continues to explore the full spectrum of berberine's benefits and mechanisms of action, solidifying its place in both traditional and modern therapeutic practices.

Berberine is primarily used for its potential benefits in managing metabolic health, including blood glucose regulation, lipid profile improvement, and weight management. It has been traditionally employed in treating various ailments, but modern research has focused significantly on its impact on metabolic disorders like type 2 diabetes and hyperlipidemia.

One of the most compelling uses of berberine is in the management of blood glucose levels. Several studies have demonstrated its efficacy in reducing fasting plasma glucose (FPG), postprandial plasma glucose (PPG), and glycated hemoglobin (HbA1c) levels. For instance, a meta-analysis published in the Endocrine Journal found that berberine treatment was associated with significant reductions in FPG, PPG, and HbA1c among type 2 diabetes patients (Liang et al., 2019). The glucose-lowering effect of berberine is considered comparable to some oral hypoglycemic drugs, making it a promising supplement for glycemic control.

In addition to its glucose-lowering properties, berberine has been shown to positively impact lipid profiles. Clinical trials and meta-analyses have reported that berberine can significantly reduce total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides, while modestly increasing high-density lipoprotein (HDL) cholesterol. A systematic review in Planta Medica reported a significant reduction in total cholesterol, triglycerides, and LDL cholesterol levels with berberine supplementation (Dong et al., 2013). These lipid-lowering effects are thought to be mediated through multiple mechanisms, including the upregulation of LDL receptors and the inhibition of cholesterol absorption in the intestines.

Berberine also holds promise in weight management and improving insulin sensitivity. Studies on both animal models and humans have indicated that berberine can enhance insulin sensitivity and reduce body weight. For example, a pilot study published in Metabolism: Clinical and Experimental found that berberine supplementation led to significant weight loss and reduced insulin resistance in type 2 diabetes patients (Yin et al., 2008). These findings are particularly relevant for individuals with metabolic syndrome, where multiple metabolic risk factors are present.

Overall, the body of scientific evidence supports the use of berberine for improving metabolic health. Its multifaceted effects on blood glucose, lipid profiles, and weight management make it a valuable supplement for those looking to enhance their overall metabolic well-being.

Berberine works through a variety of mechanisms that collectively contribute to its beneficial effects on metabolic health. The primary pathways involve modulation of glucose metabolism, lipid metabolism, and cellular signaling. Understanding these mechanisms helps explain why berberine is effective in managing conditions like type 2 diabetes and hyperlipidemia.

One of the key mechanisms by which berberine exerts its glucose-lowering effects is through the activation of AMP-activated protein kinase (AMPK). AMPK is an enzyme that plays a crucial role in cellular energy homeostasis. Activation of AMPK enhances glucose uptake in cells, increases insulin sensitivity, and stimulates glycolysis while inhibiting gluconeogenesis in the liver. A study published in the American Journal of Physiology-Endocrinology and Metabolism demonstrated that berberine activates AMPK, leading to improved glucose metabolism and insulin sensitivity (Yin et al., 2008). This activation is thought to be a consequence of increased AMP/ATP ratios, which occur due to berberine's inhibition of mitochondrial function, thereby reducing ATP production.

In terms of lipid metabolism, berberine influences cholesterol and triglyceride levels through several pathways. It upregulates the expression of low-density lipoprotein receptors (LDLR) in the liver, which enhances the clearance of LDL cholesterol from the bloodstream. Moreover, berberine has been shown to inhibit the activity of proprotein convertase subtilisin/kexin type 9 (PCSK9), a protein that degrades LDLR. By inhibiting PCSK9, berberine ensures a higher availability of LDLR on liver cells, further promoting the removal of LDL cholesterol from the blood. A study published in Atherosclerosis highlighted that berberine significantly increases LDLR expression while reducing PCSK9 levels, thereby lowering LDL cholesterol (Pirillo & Catapano, 2015).

Berberine also impacts triglyceride metabolism by modulating the expression of genes involved in lipid synthesis and fatty acid oxidation. It activates AMPK, which in turn inhibits acetyl-CoA carboxylase (ACC) and fatty acid synthase (FAS), enzymes critical for lipid biosynthesis. This leads to reduced triglyceride synthesis and increased fatty acid oxidation, contributing to lower triglyceride levels. A study in Journal of Lipid Research demonstrated that berberine inhibits lipid synthesis and reduces triglyceride levels through AMPK activation (Brusq et al., 2006).

Additionally, berberine's anti-inflammatory and antioxidant properties contribute to its overall efficacy. It reduces the levels of pro-inflammatory cytokines and oxidative stress markers, which are often elevated in metabolic disorders. These properties further enhance its ability to improve insulin sensitivity and lipid profiles.

In summary, berberine works through multiple mechanisms, including the activation of AMPK, upregulation of LDLR, inhibition of PCSK9, and modulation of lipid metabolism genes. These actions collectively contribute to its beneficial effects on glucose and lipid metabolism, making it a powerful supplement for managing metabolic health.

Berberine's application in men's and women's health can differ due to the distinct physiological and hormonal contexts of each gender. While its core benefits—such as improved metabolic health, glucose regulation, and lipid profile enhancement—apply broadly, specific issues unique to men and women can dictate its use and efficacy.

In men’s health, berberine has shown promise beyond metabolic benefits, particularly in areas related to cardiovascular health and testosterone levels. A study published in Nutrients found that berberine supplementation was associated with reductions in total cholesterol and potentially increased testosterone levels in men with hyperlipidemia (Zhao et al., 2021). The improvement in lipid profiles and the potential hormonal benefits make berberine a valuable supplement for men, especially those concerned with cardiovascular health and maintaining optimal testosterone levels. Elevated testosterone can contribute to enhanced energy levels, muscle mass retention, and overall well-being.

For women, berberine has been studied for its potential benefits in managing conditions like polycystic ovary syndrome (PCOS), which is often characterized by insulin resistance, hyperandrogenism, and irregular menstrual cycles. Berberine's ability to improve insulin sensitivity and lower androgen levels makes it particularly beneficial for women with PCOS. A systematic review published in Frontiers in Pharmacology highlighted that berberine could effectively reduce fasting plasma glucose and HbA1c levels in women with type 2 diabetes, which is relevant for those with PCOS who often exhibit similar metabolic disturbances (Xie et al., 2022). Additionally, berberine's anti-inflammatory properties can help alleviate some of the inflammatory aspects associated with PCOS.

Moreover, berberine's impact on women's health extends to its potential role in weight management and improving lipid profiles, which are crucial for reducing the risk of cardiovascular diseases. Women are particularly susceptible to cardiovascular diseases post-menopause due to the decline in protective estrogen levels. Berberine's ability to lower LDL cholesterol and triglycerides, as demonstrated in various studies, can be beneficial for postmenopausal women aiming to maintain cardiovascular health.

In summary, while berberine offers general metabolic benefits for both men and women, its specific applications can vary based on gender-specific health concerns. For men, cardiovascular health and testosterone levels are key areas where berberine can be particularly effective. For women, especially those with PCOS or postmenopausal concerns, berberine's role in improving insulin sensitivity, regulating androgens, and managing lipid profiles stands out. These gender-specific applications highlight the versatility of berberine as a supplement tailored to meet distinct health needs.

The appropriate dosage of berberine can vary based on individual health conditions, goals, and the specific formulation of the supplement. However, most studies and clinical trials have commonly used dosages ranging from 500 mg to 1,500 mg per day, often divided into two or three doses.

For metabolic health, including blood glucose regulation and lipid profile improvement, a typical dosage is 500 mg taken two to three times daily. This dosing regimen allows for sustained berberine levels in the bloodstream, which is crucial for maintaining its therapeutic effects. For instance, a study in Metabolism: Clinical and Experimental found that a dose of 500 mg taken three times a day was effective in reducing fasting blood glucose, HbA1c, and lipid levels in type 2 diabetes patients (Yin et al., 2008).

When starting berberine, it's often recommended to begin with a lower dose, such as 500 mg once daily, to assess tolerance and minimize potential gastrointestinal side effects. Once tolerance is established, the dose can be gradually increased to the therapeutic range. For some individuals, especially those with significant metabolic disturbances, a dose of up to 1,500 mg per day may be necessary to achieve the desired effects.

It's important to note that the effectiveness of berberine can be influenced by its bioavailability. Some formulations, such as berberine hydrochloride or berberine Phytosome™, are designed to enhance absorption and improve efficacy. Studies have shown that these enhanced formulations may require lower doses to achieve similar benefits compared to standard berberine extracts. For example, a clinical trial using berberine Phytosome™ showed significant improvements in glycemic and lipid profiles with a daily dose of 1,100 mg (Rondanelli et al., 2023).

In conclusion, while the general recommended dosage of berberine ranges from 500 mg to 1,500 mg per day, it is essential to start with a lower dose to assess tolerance and gradually increase as needed. Dividing the total daily dose into two or three smaller doses can help maintain consistent blood levels and enhance its therapeutic effects. As always, consult with a healthcare provider to determine the appropriate dosage based on individual health needs and conditions.

While berberine is generally well-tolerated, it can cause some side effects, particularly when taken in higher doses or when first starting supplementation. The most commonly reported side effects are gastrointestinal in nature, which can include symptoms like diarrhea, constipation, stomach cramps, and flatulence. These effects are often mild to moderate and may subside as the body adjusts to the supplement.

In a pilot study published in Metabolism: Clinical and Experimental, it was noted that approximately 34.5% of participants experienced transient gastrointestinal side effects such as diarrhea and stomach cramps when taking berberine (Yin et al., 2008). Starting with a lower dose and gradually increasing it can help mitigate these gastrointestinal issues.

Another consideration is the potential for berberine to interact with the metabolism of certain medications. Berberine has been shown to inhibit certain cytochrome P450 enzymes (CYP2D6 and CYP3A4), which are involved in the metabolism of a wide range of drugs. This inhibition can lead to increased levels of these medications in the bloodstream, potentially causing adverse effects. For example, berberine may interact with drugs like statins, blood thinners, and certain antidepressants. Therefore, monitoring for potential drug interactions is crucial, especially if you are taking other medications.

Berberine may also lower blood glucose levels effectively, which is beneficial for managing diabetes but can pose a risk of hypoglycemia, particularly when used in combination with other glucose-lowering medications. Symptoms of hypoglycemia can include dizziness, sweating, confusion, and in severe cases, loss of consciousness. It's important for individuals on diabetes medications to monitor their blood sugar levels closely when starting berberine and adjust their medication dosage under the guidance of a healthcare provider.

Lastly, although rare, some individuals may experience allergic reactions to berberine. Symptoms of an allergic reaction can include rash, itching, swelling, severe dizziness, and difficulty breathing. If any of these symptoms occur, it is important to discontinue use and seek medical attention immediately.

In summary, while berberine is generally safe for most people, it can cause gastrointestinal side effects, interact with certain medications, and potentially lead to hypoglycemia in diabetic individuals. Monitoring and adjusting dosages as needed, along with consulting a healthcare provider, can help manage these risks effectively.

Berberine, while beneficial for many, may not be suitable for everyone. Certain populations should exercise caution or avoid berberine supplementation altogether due to potential risks and interactions.

Firstly, pregnant and breastfeeding women should avoid berberine. There is limited research on the safety of berberine during pregnancy and lactation, and it is known that berberine can cross the placenta and may cause harm to the fetus. Similarly, because berberine can be excreted in breast milk, it may pose risks to a nursing infant. Therefore, it is generally advised that pregnant or breastfeeding women refrain from using berberine supplements.

Individuals with certain medical conditions should also avoid berberine. For example, people with low blood pressure or a history of hypotension should be cautious, as berberine has been shown to lower blood pressure, which could exacerbate hypotensive conditions. Additionally, those with severe liver or kidney disease should avoid berberine due to potential alterations in drug metabolism and excretion, which can lead to adverse effects.

Children should also avoid berberine unless under the supervision of a healthcare provider. The safety and efficacy of berberine in children have not been well-studied, and the potential risks may outweigh the benefits.

People taking certain medications should be particularly cautious. Berberine can interact with a variety of drugs by inhibiting cytochrome P450 enzymes (CYP2D6 and CYP3A4), leading to increased blood levels of these medications and a higher risk of adverse effects. For instance, individuals on blood thinners like warfarin, immunosuppressants, certain antidepressants, or statins should consult their healthcare provider before taking berberine. The interaction between berberine and these medications can lead to significant complications, including increased risk of bleeding, toxicity, or adverse drug reactions.

Lastly, individuals with hypoglycemia or those taking antidiabetic medications should monitor their blood glucose levels closely when using berberine. Berberine’s potent glucose-lowering effects could cause blood sugar levels to drop too low, leading to hypoglycemia. Symptoms of hypoglycemia include dizziness, confusion, sweating, and in severe cases, loss of consciousness. It's crucial for individuals on glucose-lowering medications to adjust their dosages under medical supervision when starting berberine.

In summary, while berberine offers numerous health benefits, it may not be suitable for pregnant or breastfeeding women, individuals with certain medical conditions, children, and those on specific medications. Consulting with a healthcare provider is essential to determine whether berberine is appropriate for your individual health needs and circumstances.

Yes, berberine supplements are known to interact with several medications, primarily due to its influence on the cytochrome P450 enzymes (CYP2D6 and CYP3A4) and its ability to modulate various metabolic pathways. These interactions can lead to altered drug efficacy and potentially serious side effects.

One of the most significant interactions is with medications that are metabolized by the cytochrome P450 enzymes. Berberine inhibits these enzymes, which can increase the blood levels of drugs that are metabolized by CYP2D6 and CYP3A4, potentially leading to toxicity. For example, if you are taking statins for cholesterol management, berberine may increase the concentration of these drugs in your bloodstream, heightening the risk of muscle pain, liver damage, or other statin-related side effects. A study published in Atherosclerosis highlighted that berberine significantly affects the metabolism of statins, emphasizing the need for careful monitoring (Pirillo & Catapano, 2015).

Another important interaction is with blood thinners, such as warfarin. Berberine can enhance the effects of warfarin, increasing the risk of bleeding. This interaction is particularly concerning because it can lead to serious complications such as gastrointestinal bleeding or hemorrhagic stroke. Regular monitoring of blood clotting parameters (e.g., INR) is essential if berberine and warfarin are used concurrently.

Berberine also interacts with medications used to manage blood sugar levels, such as metformin and insulin. While berberine itself has glucose-lowering properties, combining it with these medications can amplify their effects, potentially leading to hypoglycemia. Symptoms of hypoglycemia include dizziness, confusion, sweating, and even loss of consciousness. Monitoring blood glucose levels closely and adjusting the dosage of antidiabetic medications under medical supervision is crucial when adding berberine to the regimen.

Additionally, berberine can interact with immunosuppressants such as cyclosporine and tacrolimus. By inhibiting their metabolism, berberine can increase the levels of these drugs in the blood, raising the risk of nephrotoxicity and other adverse effects. This is particularly important for patients who have undergone organ transplantation, as maintaining appropriate immunosuppressant levels is critical for preventing organ rejection.

Furthermore, berberine may interact with certain antidepressants, particularly those metabolized by CYP2D6 and CYP3A4. This can lead to increased blood levels of the antidepressants, heightening the risk of side effects such as serotonin syndrome, a potentially life-threatening condition characterized by agitation, confusion, rapid heart rate, and high blood pressure.

In summary, berberine supplements can interact with a range of medications, including statins, blood thinners, antidiabetic drugs, immunosuppressants, and certain antidepressants. These interactions can lead to increased drug levels and a higher risk of adverse effects. It is essential to consult with a healthcare provider before starting berberine, especially if you are taking any medications that may interact with it, to ensure safe and effective use.

Berberine is a natural alkaloid found in several plants, particularly in the roots, rhizomes, and stems. The best sources of berberine are plants from the Berberis genus, as well as a few other botanical species. Here are some of the most notable sources:

1. Berberis Aristata (Indian Barberry or Tree Turmeric): This plant is one of the richest sources of berberine. It has been used traditionally in Ayurvedic medicine for its antimicrobial and anti-inflammatory properties. The root and stem bark of Berberis aristata are commonly used to extract berberine.
2. Berberis Vulgaris (European Barberry): Another significant source of berberine, Berberis vulgaris, has been used in traditional European medicine. The root, bark, and stem of this plant are the primary parts used for berberine extraction.
3. Coptis Chinensis (Chinese Goldthread): Widely used in traditional Chinese medicine, this plant is known for its high berberine content. The rhizomes of Coptis chinensis are particularly rich in berberine and are used to treat various gastrointestinal disorders and infections.
4. Hydrastis Canadensis (Goldenseal): Native to North America, Goldenseal is another potent source of berberine. It has been used by Native Americans for its medicinal properties, especially for treating infections and digestive issues. The root and rhizome of Goldenseal are utilized for berberine extraction.
5. Phellodendron Amurense (Amur Cork Tree): This plant, commonly used in traditional Chinese medicine, is another good source of berberine. The bark of Phellodendron amurense is rich in berberine and is often used in herbal formulations for its anti-inflammatory and antimicrobial properties.

When choosing a berberine supplement, it is essential to consider the source and quality of the extract. High-quality supplements will typically specify the plant source and the part of the plant used for extraction. Look for supplements that use standardized extracts to ensure consistent berberine content.

In addition to plant sources, berberine supplements come in various formulations to enhance bioavailability and efficacy. These include berberine hydrochloride, which is the most common form, and berberine Phytosome™, which combines berberine with phospholipids to improve absorption. Research has shown that these enhanced formulations can be more effective at lower doses compared to standard extracts (Rondanelli et al., 2023).

In summary, the best sources of berberine are plants such as Berberis aristata, Berberis vulgaris, Coptis chinensis, Hydrastis canadensis, and Phellodendron amurense. When selecting a berberine supplement, ensure it comes from a reputable source and consider formulations that enhance bioavailability for better results.

Berberine is available in various forms to cater to different preferences and increase its bioavailability. The most common forms include capsules, tablets, powders, and liquid extracts. Each form has its unique advantages and considerations, making it easier for individuals to choose the one that best suits their needs.

1. Capsules: Capsules are one of the most popular forms of berberine supplements. They are convenient, easy to swallow, and often come in pre-measured doses, ensuring consistency and ease of use. Many high-quality berberine capsules contain berberine hydrochloride, which is known for its stability and efficacy. Some formulations may also include additional ingredients like phospholipids to enhance absorption.
2. Tablets: Similar to capsules, tablets provide a convenient and consistent dosage form. They are typically made by compressing berberine powder into a solid form. Tablets may also contain other ingredients to aid in the tablet formation, such as binders and fillers. Some people prefer tablets over capsules due to their compact size and ease of storage.
3. Powders: Berberine powder offers a versatile option for those who prefer to mix the supplement into drinks or food. This form allows for flexible dosing, as users can measure the exact amount they need. However, the bitter taste of berberine can be a drawback when using the powder form. It's essential to measure the dosage accurately to avoid taking too much or too little.
4. Liquid Extracts: Liquid extracts are another form of berberine supplements, often made by dissolving berberine in a solvent like alcohol or glycerin. This form can be beneficial for individuals who have difficulty swallowing capsules or tablets. Liquid extracts may offer faster absorption compared to solid forms, but the taste can be quite strong and bitter. Measuring the correct dosage is also crucial when using liquid extracts.
5. Enhanced Formulations: To improve the bioavailability of berberine, some manufacturers offer enhanced formulations. One such example is berberine Phytosome™, which combines berberine with phospholipids to create a complex that is more easily absorbed by the body. Studies have shown that these enhanced formulations can provide better therapeutic effects at lower doses compared to standard berberine extracts (Rondanelli et al., 2023).

When selecting a berberine supplement, it's essential to consider factors such as convenience, dosage accuracy, bioavailability, and personal preferences. Capsules and tablets are generally the most convenient and widely used forms, while powders and liquid extracts offer flexibility in dosing and application. Enhanced formulations like berberine Phytosome™ can provide superior absorption and efficacy, making them an attractive option for those seeking maximum benefits from their supplement.

In summary, berberine is available in various forms, including capsules, tablets, powders, liquid extracts, and enhanced formulations. Each form has its advantages and considerations, allowing individuals to choose the best option based on their preferences and needs.

Berberine itself is a potent bioactive compound, but it can be metabolized into several sub-compounds that may contribute to its overall efficacy. These metabolites are produced as berberine undergoes biotransformation in the body, primarily in the liver. Among the various metabolites, a few are particularly noteworthy due to their potential roles in enhancing the therapeutic effects of berberine.

1. Berberrubine: This is one of the primary metabolites of berberine. Research has indicated that berberrubine retains much of the biological activity of berberine and may even exhibit stronger effects in certain contexts. For instance, berberrubine has been shown to upregulate low-density lipoprotein receptors (LDLR) in liver cells, similar to berberine, thereby contributing to its lipid-lowering effects (Zhou et al., 2014). This metabolite may also play a role in glucose metabolism and anti-inflammatory responses.
2. Dihydroberberine: Dihydroberberine is another significant metabolite that has gained attention for its enhanced bioavailability compared to berberine. Studies have demonstrated that dihydroberberine is more readily absorbed and converted back into berberine within the body, leading to higher plasma concentrations. This enhanced bioavailability can make dihydroberberine particularly effective in improving glycemic control and lipid profiles. A study published in Nutrients highlighted the superior absorption of dihydroberberine and its potential benefits in managing blood glucose levels (Moon et al., 2021).
3. Jatrorrhizine: Another metabolite of berberine, jatrorrhizine, has been found to contribute to the overall therapeutic effects, particularly in lipid metabolism. It has been observed to upregulate LDLR expression and inhibit lipid accumulation in liver cells, much like berberine. This suggests that jatrorrhizine may play an auxiliary role in enhancing berberine's lipid-lowering properties (Zhou et al., 2014).
4. Other Metabolites: Additional metabolites, such as columbamine and demethyleneberberine, also exhibit biological activities that may support the efficacy of berberine. These compounds have shown potential in modulating lipid metabolism, reducing oxidative stress, and exerting anti-inflammatory effects. While their individual contributions may vary, the collective activity of these metabolites enhances the overall therapeutic profile of berberine.

The presence and activity of these metabolites underscore the importance of considering berberine's biotransformation when evaluating its efficacy. Enhanced formulations, such as berberine Phytosome™, aim to improve the bioavailability of berberine and its metabolites, ensuring that higher concentrations reach systemic circulation for maximum therapeutic benefit.

In summary, critical metabolites such as berberrubine, dihydroberberine, and jatrorrhizine play significant roles in the efficacy of berberine. These sub-compounds contribute to the lipid-lowering, glucose-regulating, and anti-inflammatory effects of berberine, enhancing its overall therapeutic potential. Understanding and leveraging these metabolites can help optimize the use of berberine supplements for various health benefits.

Berberine is known by several names and has various abbreviations, common misspellings, and related chemical compounds. These alternate names and terms can be helpful to know, especially when researching the supplement or looking for it in different contexts.

Alternate Names and Chemical Compounds:

1. Berberine Chloride: This is a common form of berberine used in supplements.
2. Berberine Hydrochloride (Berberine HCl): Another popular form, often used to enhance stability and absorption.
3. Berberine Sulfate: A less common form of berberine.
4. Hydrastine: Sometimes confused with berberine, hydrastine is another alkaloid found in Goldenseal (Hydrastis canadensis), a common source of berberine.
5. Berberrubine: A metabolite of berberine that retains similar biological activity.
6. Dihydroberberine: A reduced form of berberine with enhanced bioavailability.
7. Jatrorrhizine: An alkaloid closely related to berberine, often found in the same plant sources.

Common Misspellings and Abbreviations:

1. Berberin: A common misspelling that drops the final "e."
2. Barberine: Another misspelling that replaces the first "e" with an "a."
3. BBR: A common abbreviation used in scientific literature and discussions.
4. Hydrastis: Refers to the Goldenseal plant, a common source of berberine.
5. Coptis: Refers to Coptis chinensis, another plant source of berberine, often used in traditional Chinese medicine.

Other Related Ingredients:

1. Goldenseal (Hydrastis canadensis): A North American plant rich in berberine.
2. Oregon Grape (Mahonia aquifolium): Another plant that contains berberine.
3. Barberry (Berberis vulgaris): A plant from which berberine is commonly extracted.
4. Tree Turmeric (Berberis aristata): Known for its high berberine content, used in Ayurvedic medicine.
5. Coptis (Coptis chinensis): Also known as Chinese Goldthread, a significant source of berberine in traditional Chinese medicine.

Berberine is widely recognized for its diverse health benefits, particularly in managing metabolic health. Its various forms, related compounds, and alternate names can help individuals identify the supplement in different contexts and ensure they are choosing the right product for their needs.

In summary, berberine is known by several names, including Berberine Chloride, Berberine Hydrochloride, and Berberine Sulfate. It is often abbreviated as BBR and has related compounds like berberrubine and dihydroberberine. Common sources include Goldenseal, Oregon Grape, Barberry, and Tree Turmeric. Understanding these names and compounds can aid in selecting the appropriate berberine supplement and recognizing its various formulations and sources.

When selecting a berberine supplement, it is essential to scrutinize the product label to ensure quality, efficacy, and safety. Here are several critical factors to look for:

1. Standardized Extract: Ensure the label specifies that the berberine content is standardized. This means the supplement contains a consistent and verified amount of berberine, typically indicated as a percentage or a specific milligram amount. A standardized extract ensures that each dose provides the intended therapeutic effect.
2. Form of Berberine: Look for the specific form of berberine used in the supplement. Common forms include berberine hydrochloride (HCl), berberine sulfate, and enhanced formulations like berberine Phytosome™. Berberine HCl is widely studied and known for its stability and efficacy. Enhanced formulations, such as berberine Phytosome™, combine berberine with phospholipids to improve bioavailability.
3. Dosage Information: Check the dosage per serving to ensure it aligns with the amounts used in clinical studies. Typical effective dosages range from 500 mg to 1,500 mg per day, often divided into two or three doses. Ensure that the supplement provides a convenient and effective dosage.
4. Additional Ingredients: Review the list of additional ingredients. Some supplements may include other compounds to enhance absorption or provide complementary benefits. For example, some formulations include silymarin (from milk thistle) or phospholipids to improve bioavailability. Ensure that any additional ingredients are safe and beneficial.
5. Third-Party Testing and Certification: Look for evidence of third-party testing or certification on the label. Reputable supplements often undergo independent testing to verify their purity, potency, and quality. Certifications from organizations like NSF International, USP (United States Pharmacopeia), or ConsumerLab indicate that the product meets high standards for quality and safety.
6. Manufacturer Information: Ensure the label includes information about the manufacturer, including their name and contact details. A reputable manufacturer will provide transparency about their practices and be available to answer any questions regarding their product.
7. Expiration Date and Lot Number: Check for an expiration date to ensure the supplement is fresh and effective. The lot number is also important as it allows for traceability in case of recalls or quality issues.
8. Free from Contaminants: Ensure the label states that the product is free from common contaminants such as heavy metals, pesticides, and microbial impurities. Some high-quality supplements will explicitly mention that they have been tested for these contaminants.
9. Absence of Fillers and Additives: Look for a supplement that minimizes the use of unnecessary fillers, binders, and artificial additives. A cleaner ingredient list often indicates a higher quality product.
10. Allergen Information: Check the label for any potential allergens, especially if you have known allergies. Common allergens such as gluten, soy, dairy, and nuts should be clearly indicated.

In summary, when selecting a berberine supplement, look for standardized extracts, the specific form of berberine, appropriate dosage information, additional beneficial ingredients, third-party testing and certification, manufacturer transparency, expiration date and lot number, absence of contaminants, minimal fillers and additives, and clear allergen information. These factors can help ensure you choose a high-quality and effective berberine supplement.

The information provided on this website, including any text, images, or other material contained within, is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. This page was created by the SuppCo editiorial team, with AI summarization tools, including data from but not limited to following studies:

1. A. Pirillo, A. Catapano (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.. Atherosclerosis, 243 2,
   449-61 . Link: 10.1016/j.atherosclerosis.2015.09.032
2. X. Xia, Jinhua Yan, Yun-feng Shen, Kuan-xiao Tang, Jun-yi Yin, Yanhua Zhang, Dongjie Yang, Hua Liang, Jianping Ye, J. Weng (2011). Berberine Improves Glucose Metabolism in Diabetic Rats by Inhibition of Hepatic Gluconeogenesis. PLoS ONE, 6, . Link: 10.1371/journal.pone.0016556
3. S. Leng, F. Lu, Li-jun Xu (2004). Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion.. Acta pharmacologica Sinica, 25 4,
   496-502 . Link:
4. Jun-yi Yin, Zhanguo Gao, Dong Liu, Zhijun Liu, Jianping Ye (2008). Berberine improves glucose metabolism through induction of glycolysis.. American journal of physiology. Endocrinology and metabolism, 294 1,
   E148-56 . Link: 10.1152/AJPENDO.00211.2007
5. Yanwen Wang, T. Campbell, B. Perry, C. Beaurepaire, Ling Qin (2011). Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.. Metabolism: clinical and experimental, 60 2,
   298-305 . Link: 10.1016/j.metabol.2010.02.005
6. Yaping Liang, Xiaojia Xu, Mingjuan Yin, Yan Zhang, Lingfeng Huang, Ruoling Chen, J. Ni (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis.. Endocrine journal, 66 1,
   51-63 . Link: 10.1507/endocrj.EJ18-0109
7. Hao Zhang, Jing Wei, R. Xue, Jindan Wu, Wei Zhao, Zi-zheng Wang, Shu-kui Wang, Zheng-Xian Zhou, Danqing Song, Yue‐ming Wang, Huaining Pan, Wei-Jia Kong, Jian-Dong Jiang (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.. Metabolism: clinical and experimental, 59 2,
   285-92 . Link: 10.1016/j.metabol.2009.07.029
8. Yifei Zhang, Xiaoying Li, D. Zou, Wei Liu, Jialin Yang, N. Zhu, L. Huo, Miao Wang, Jie Hong, Peihong Wu, G. Ren, G. Ning (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.. The Journal of clinical endocrinology and metabolism, 93 7,
   2559-65 . Link: 10.1210/jc.2007-2404
9. Jun-yi Yin, Huili Xing, Jianping Ye (2008). Efficacy of berberine in patients with type 2 diabetes mellitus.. Metabolism: clinical and experimental, 57 5,
   712-7 . Link: 10.1016/j.metabol.2008.01.013
10. Wenting Xie, F. Su, Guizhong Wang, Zichong Peng, Yaomin Xu, Yi Zhang, Ningning Xu, Kaijian Hou, Zhuping Hu, Yan Chen, Rong-ping Chen (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, . Link: 10.3389/fphar.2022.1015045
11. Jie V. Zhao, W. Yeung, Y. Chan, D. Vackova, J. Y. Leung, D. Ip, Jiaxi Zhao, Wai-Kwan Ho, H. Tse, C. Schooling (2021). Effect of Berberine on Cardiovascular Disease Risk Factors: A Mechanistic Randomized Controlled Trial. Nutrients, 13, . Link: 10.3390/nu13082550
12. Hui Dong, Yan Zhao, Li Zhao, F. Lu (2013). The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Planta Medica, 79, 437 - 446. Link: 10.1055/s-0032-1328321
13. X. Jia, Yanfeng Chen, J. Zidichouski, Junzeng Zhang, Changhao Sun, Yanwen Wang (2008). Co-administration of berberine and plant stanols synergistically reduces plasma cholesterol in rats.. Atherosclerosis, 201 1,
    101-7 . Link: 10.1016/j.atherosclerosis.2008.03.008
14. Yanwen Wang, X. Jia, K. Ghanam, C. Beaurepaire, J. Zidichouski, Lisa M. Miller (2010). Berberine and plant stanols synergistically inhibit cholesterol absorption in hamsters.. Atherosclerosis, 209 1,
    111-7 . Link: 10.1016/j.atherosclerosis.2009.08.050
15. F. Affuso, A. Ruvolo, F. Micillo, L. Saccá, S. Fazio (2010). Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 20 9,
    656-61 . Link: 10.1016/j.numecd.2009.05.017
16. S. Doggrell (2005). Berberine – a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14, 683 - 685. Link: 10.1517/13543784.14.5.683
17. A. Pirillo, A. Catapano (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.. Atherosclerosis, 243 2,
    449-61 . Link: 10.1016/j.atherosclerosis.2015.09.032
18. Yanwen Wang, Xin Yi, K. Ghanam, Shuocheng Zhang, Tiantian Zhao, Xuemei Zhu (2014). Berberine decreases cholesterol levels in rats through multiple mechanisms, including inhibition of cholesterol absorption.. Metabolism: clinical and experimental, 63 9,
    1167-77 . Link: 10.1016/j.metabol.2014.05.013
19. A. Hernandez, J. Hwang, Iram Nasreen, Dakota J Sicignano, V. Pasupuleti, Kimberly Snow-Caroti, C. M. White (2023). Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.. Journal of dietary supplements, ,
    1-18 . Link: 10.1080/19390211.2023.2212762
20. M. Rondanelli, C. Gasparri, G. Petrangolini, P. Allegrini, D. Avenoso, T. Fazia, L. Bernardinelli, G. Peroni, Z. Patelli, F. Mansueto, A. Tartara, A. Cavioni, A. Riva (2023). Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial.. European review for medical and pharmacological sciences, 27 14,
    6718-6727 . Link: 10.26355/eurrev_202307_33142
21. M. Rondanelli, C. Gasparri, G. Petrangolini, P. Allegrini, D. Avenoso, T. Fazia, L. Bernardinelli, G. Peroni, Z. Patelli, F. Mansueto, A. Tartara, A. Cavioni, A. Riva (2023). Berberine phospholipid exerts a positive effect on the glycemic profile of overweight subjects with impaired fasting blood glucose (IFG): a randomized double-blind placebo-controlled clinical trial.. European review for medical and pharmacological sciences, 27 14,
    6718-6727 . Link: 10.26355/eurrev_202307_33142
22. Jun-yi Yin, Huili Xing, Jianping Ye (2008). Efficacy of berberine in patients with type 2 diabetes mellitus.. Metabolism: clinical and experimental, 57 5,
    712-7 . Link: 10.1016/j.metabol.2008.01.013
23. Jessica M. Moon, K. Ratliff, Anthony M. Hagele, R. Stecker, Petey W. Mumford, C. Kerksick (2021). Absorption Kinetics of Berberine and Dihydroberberine and Their Impact on Glycemia: A Randomized, Controlled, Crossover Pilot Trial. Nutrients, 14, . Link: 10.3390/nu14010124
24. Yaping Liang, Xiaojia Xu, Mingjuan Yin, Yan Zhang, Lingfeng Huang, Ruoling Chen, J. Ni (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis.. Endocrine journal, 66 1,
    51-63 . Link: 10.1507/endocrj.EJ18-0109
25. Jun-yi Yin, Zhanguo Gao, Dong Liu, Zhijun Liu, Jianping Ye (2008). Berberine improves glucose metabolism through induction of glycolysis.. American journal of physiology. Endocrinology and metabolism, 294 1,
    E148-56 . Link: 10.1152/AJPENDO.00211.2007
26. Z. Safari, A. Farrokhzad, A. Ghavami, Abdulmnannan Fadel, A. Hadi, S. Rafiee, Amin Mokari-Yamchi, G. Askari (2020). The effect of barberry (Berberis vulgaris L.) on glycemic indices: A systematic review and meta-analysis of randomized controlled trials.. Complementary therapies in medicine, 51,
    102414 . Link: 10.1016/j.ctim.2020.102414
27. F. Di Pierro, N. Villanova, F. Agostini, R. Marzocchi, V. Soverini, G. Marchesini (2012). Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 5, 213 - 217. Link: 10.2147/DMSO.S33718
28. H. Rashidi, F. Namjoyan, Z. Mehraban, Mehrnoosh Zakerkish, S. Ghaderian, S. Latifi (2018). The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients. Jundishapur Journal of Natural Pharmaceutical Products, 13, . Link: 10.5812/JJNPP.64180
29. A. Pirillo, A. Catapano (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.. Atherosclerosis, 243 2,
    449-61 . Link: 10.1016/j.atherosclerosis.2015.09.032
30. Yanwen Wang, T. Campbell, B. Perry, C. Beaurepaire, Ling Qin (2011). Hypoglycemic and insulin-sensitizing effects of berberine in high-fat diet- and streptozotocin-induced diabetic rats.. Metabolism: clinical and experimental, 60 2,
    298-305 . Link: 10.1016/j.metabol.2010.02.005
31. Shujun Jiang, Hui Dong, Jingbin Li, Li-jun Xu, Xin Zou, Kai-fu Wang, F. Lu, P. Yi (2015). Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.. World journal of gastroenterology, 21 25,
    7777-85 . Link: 10.3748/wjg.v21.i25.7777
32. Wenting Xie, F. Su, Guizhong Wang, Zichong Peng, Yaomin Xu, Yi Zhang, Ningning Xu, Kaijian Hou, Zhuping Hu, Yan Chen, Rong-ping Chen (2022). Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis. Frontiers in Pharmacology, 13, . Link: 10.3389/fphar.2022.1015045
33. Yifei Zhang, Xiaoying Li, D. Zou, Wei Liu, Jialin Yang, N. Zhu, L. Huo, Miao Wang, Jie Hong, Peihong Wu, G. Ren, G. Ning (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.. The Journal of clinical endocrinology and metabolism, 93 7,
    2559-65 . Link: 10.1210/jc.2007-2404
34. Yaping Liang, Xiaojia Xu, Mingjuan Yin, Yan Zhang, Lingfeng Huang, Ruoling Chen, J. Ni (2019). Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis.. Endocrine journal, 66 1,
    51-63 . Link: 10.1507/endocrj.EJ18-0109
35. Yang-Sheng Wu, Yi-Tao Chen, Y. Bao, Zheming Li, Xiaojie Zhou, Jia-Na He, Shijie Dai, C. Li (2016). Identification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics Analysis. PLoS ONE, 11, . Link: 10.1371/journal.pone.0166378
36. J. Ming, Xinwen Yu, Xiaoqiang Xu, Li Wang, Chao Ding, Zhifeng Wang, Xuan Xie, Sheli Li, Wenjuan Yang, Shu Luo, Qingzhen He, Yafang Du, Zhufang Tian, Xiling Gao, Kaiyan Ma, Yujie Fang, Chen Li, Jiajun Zhao, Xiaokai Wang, Q. Ji (2021). Effectiveness and safety of Bifidobacterium and berberine in human hyperglycemia and their regulatory effect on the gut microbiota: a multi-center, double-blind, randomized, parallel-controlled study. Genome Medicine, 13, . Link: 10.1186/s13073-021-00942-7
37. Jiarong Lan, Yanyun Zhao, Feixia Dong, Ziyou Yan, W. Zheng, Jinping Fan, G. Sun (2015). Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension.. Journal of ethnopharmacology, 161,
    69-81 . Link: 10.1016/j.jep.2014.09.049
38. Jing Guo, Hongdong Chen, Xueqin Zhang, Wenjiao Lou, Pingna Zhang, Y. Qiu, Chao Zhang, Yaoxian Wang, Wei Jing Liu (2021). The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Oxidative Medicine and Cellular Longevity, 2021, . Link: 10.1155/2021/2074610
39. Jun-yi Yin, Huili Xing, Jianping Ye (2008). Efficacy of berberine in patients with type 2 diabetes mellitus.. Metabolism: clinical and experimental, 57 5,
    712-7 . Link: 10.1016/j.metabol.2008.01.013
40. Wang Zhang, Jihao Xu, Tao Yu, Qi-Kui Chen (2019). Effects of berberine and metformin on intestinal inflammation and gut microbiome composition in db/db mice.. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 118,
    109131 . Link: 10.1016/j.biopha.2019.109131
41. Hui Dong, Yan Zhao, Li Zhao, F. Lu (2013). The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Planta Medica, 79, 437 - 446. Link: 10.1055/s-0032-1328321
42. Y. Hsieh, Wu‐Hsien Kuo, Ta-Wei Lin, Horng-Rong Chang, T. Lin, Pei-Ni Chen, S. Chu (2007). Protective effects of berberine against low-density lipoprotein (LDL) oxidation and oxidized LDL-induced cytotoxicity on endothelial cells.. Journal of agricultural and food chemistry, 55 25,
    10437-45 . Link: 10.1021/JF071868C
43. Yan Zhou, Shijie Cao, Ying Wang, Peixiang Xu, Jiankun Yan, Wen Bin, F. Qiu, Ning Kang (2014). Berberine metabolites could induce low density lipoprotein receptor up-regulation to exert lipid-lowering effects in human hepatoma cells.. Fitoterapia, 92,
    230-7 . Link: 10.1016/j.fitote.2013.11.010
44. V. Spigoni, R. Aldigeri, M. Antonini, M. Micheli, Federica Fantuzzi, A. Fratter, M. Pellizzato, E. Derlindati, I. Zavaroni, R. Bonadonna, A. Dei Cas (2017). Effects of a New Nutraceutical Formulation (Berberine, Red Yeast Rice and Chitosan) on Non-HDL Cholesterol Levels in Individuals with Dyslipidemia: Results from a Randomized, Double Blind, Placebo-Controlled Study. International Journal of Molecular Sciences, 18, . Link: 10.3390/ijms18071498
45. P. Abidi, Yue Zhou, Jian-Dong Jiang, Jingwen Liu (2005). Extracellular Signal-Regulated Kinase–Dependent Stabilization of Hepatic Low-Density Lipoprotein Receptor mRNA by Herbal Medicine Berberine. Arteriosclerosis, Thrombosis, and Vascular Biology, 25, 2170-2176. Link: 10.1161/01.ATV.0000181761.16341.2b
46. Hong-Bo Xiao, Zhi-Liang Sun, Heng-Bo Zhang, Da-Sheng Zhang (2012). Berberine inhibits dyslipidemia in C57BL/6 mice with lipopolysaccharide induced inflammation. Pharmacological Reports, 64, 889-895. Link: 10.1016/S1734-1140(12)70883-6
47. A. Hernandez, J. Hwang, Iram Nasreen, Dakota J Sicignano, V. Pasupuleti, Kimberly Snow-Caroti, C. M. White (2023). Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.. Journal of dietary supplements, ,
    1-18 . Link: 10.1080/19390211.2023.2212762
48. Yinghong Li, Peng Yang, Wei-Jia Kong, Yanxiang Wang, Chang-qin Hu, Z. Zuo, Yue‐ming Wang, Hong-Jiao Gao, Li-mei Gao, Yan-Chun Feng, Na-na Du, Y. Liu, Danqing Song, Jian-Dong Jiang (2009). Berberine analogues as a novel class of the low-density-lipoprotein receptor up-regulators: synthesis, structure-activity relationships, and cholesterol-lowering efficacy.. Journal of medicinal chemistry, 52 2,
    492-501 . Link: 10.1021/jm801157z
49. Nathalia Luiza Andreazza, Christine Vevert-Bizet, G. Bourg-Heckly, F. Sureau, Marcos José Salvador, Stephanie Bonneau (2016). Berberine as a photosensitizing agent for antitumoral photodynamic therapy: Insights into its association to low density lipoproteins.. International journal of pharmaceutics, 510 1,
    240-9 . Link: 10.1016/j.ijpharm.2016.06.009
50. S. Doggrell (2005). Berberine – a novel approach to cholesterol lowering. Expert Opinion on Investigational Drugs, 14, 683 - 685. Link: 10.1517/13543784.14.5.683
51. Shijie Cao, Sheng-Yung Yu, Li-yuan Cheng, Jiankun Yan, Yan Zhu, Yanru Deng, F. Qiu, Ning Kang (2018). 9-O-benzoyl-substituted berberine exerts a triglyceride-lowering effect through AMPK signaling pathway in human hepatoma HepG2 cells.. Environmental toxicology and pharmacology, 64,
    11-17 . Link: 10.1016/j.etap.2018.09.007
52. Hui Dong, Yan Zhao, Li Zhao, F. Lu (2013). The Effects of Berberine on Blood Lipids: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Planta Medica, 79, 437 - 446. Link: 10.1055/s-0032-1328321
53. J. Brusq, N. Ancellin, P. Grondin, Raphaelle Guillard, Sandrine Martin, Yannick Saintillan, M. Issandou (2006). Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine Published, JLR Papers in Press, February 28, 2006.. Journal of Lipid Research, 47, 1281 - 1288. Link: 10.1194/jlr.M600020-JLR200
54. A. Hernandez, J. Hwang, Iram Nasreen, Dakota J Sicignano, V. Pasupuleti, Kimberly Snow-Caroti, C. M. White (2023). Impact of Berberine or Berberine Combination Products on Lipoprotein, Triglyceride and Biological Safety Marker Concentrations in Patients with Hyperlipidemia: A Systematic Review and Meta-Analysis.. Journal of dietary supplements, ,
    1-18 . Link: 10.1080/19390211.2023.2212762
55. F. Affuso, A. Ruvolo, F. Micillo, L. Saccá, S. Fazio (2010). Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.. Nutrition, metabolism, and cardiovascular diseases : NMCD, 20 9,
    656-61 . Link: 10.1016/j.numecd.2009.05.017
56. A. Singh, Jingwen Liu (2019). Berberine decreases plasma triglyceride levels and upregulates hepatic TRIB1 in LDLR wild type mice and in LDLR deficient mice. Scientific Reports, 9, . Link: 10.1038/s41598-019-52253-y
57. Jun-yi Yin, Huili Xing, Jianping Ye (2008). Efficacy of berberine in patients with type 2 diabetes mellitus.. Metabolism: clinical and experimental, 57 5,
    712-7 . Link: 10.1016/j.metabol.2008.01.013
58. A. Pirillo, A. Catapano (2015). Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.. Atherosclerosis, 243 2,
    449-61 . Link: 10.1016/j.atherosclerosis.2015.09.032
59. Yifei Zhang, Xiaoying Li, D. Zou, Wei Liu, Jialin Yang, N. Zhu, L. Huo, Miao Wang, Jie Hong, Peihong Wu, G. Ren, G. Ning (2008). Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine.. The Journal of clinical endocrinology and metabolism, 93 7,
    2559-65 . Link: 10.1210/jc.2007-2404
60. Lishuang Zhang, Jun-Hua Zhang, Rui Feng, Xinyao Jin, Fengwen Yang, Z. Ji, Meng Zhao, Mingyan Zhang, Bo-Li Zhang, Xue-mei Li (2019). Efficacy and Safety of Berberine Alone or Combined with Statins for the Treatment of Hyperlipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.. The American journal of Chinese medicine, 47 4,
    751-767 . Link: 10.1142/S0192415X19500393